Prevalence of Diabetic Retinopathy Among Diabetic Patients At Ophthalmology Department of Combined Military Hospital, Sialkot

Muhammad Asif Sadiq; Mariyum Munir Khokhar

doi:10.51253/pafmj.v76iSUPPL-2.13621

Authors

Muhammad Asif Sadiq Department of Ophthalmology, Combined Military Hospital Sialkot/National University of Medical Sciences (NUMS) Pakistan
Mariyum Munir Khokhar Department of Ophthalmology, Combined Military Hospital Sialkot/National University of Medical Sciences (NUMS) Pakistan

DOI:

https://doi.org/10.51253/pafmj.v76iSUPPL-2.13621

Keywords:

Diabetes, Fundus, Retinopathy

Abstract

Objective: To determine the frequency of diabetic retinopathy among diabetic patients presenting to the Eye Department of Combined Military Hospital, Sialkot.

Study Design: Cross- sectional study.

Place and Duration of Study: Department of Ophthalmology, Combined Military Hospital Sialkot, Pakistan from Sep 2021 to Jan 2023.

Methodology: A total of 500 patients aged 20 to 70 years, with a known diagnosis of diabetes mellitus and undergoing anti-diabetic treatment, were enrolled. Fundus examination was performed on all participants to detect and grade diabetic retinopathy (DR), using International DR severity scale. Statistical analysis was carried out using SPSS version 20. The Chi-square test was applied to assess associations between the presence of DR and various demographic variables.

Results: Out of 500 diabetic patients, 297(59.4%) were male and 203(40.6%) females, with a mean age of 56.40±2.75 years. Diabetic retinopathy (DR) was present in 138 patients (27.6%). Among these, 120(24.0%) had non-proliferative DR: mild in 98(19.6%), moderate in 13(2.6%), and severe in 9(1.8%). Proliferative DR and advanced diabetic eye disease were observed in 12(2.4%) and 6(1.2%) patients, respectively. DR was significantly more prevalent among females (p < 0.001), with no significant association with age (p = 0.525).

Conclusion: The frequency of diabetic retinopathy in diabetic population was found to be high, which highlights the need for screening programs, to prevent vision-threatening complications.

Downloads

Download data is not yet available.

References

1. Bastaki S. Diabetes mellitus and its treatment. Int J Diabetes Metab 2019; 13: 111–134. https://doi.org/10.1159/000497580.

2. Yang Z, Tan TE, Shao Y, Wong TY, Li X. Classification of diabetic retinopathy: Past, present and future. Front Endocrinol 2022; 13: 1079217.

https://doi.org/10.3389/fendo.2022.1079217

3. Rother KI. Diabetes treatment—bridging the divide. N Engl J Med 2007 ; 356(15): 1499.

https://doi.org/10.1056/NEJMp078030.

4. Ansari P, Tabassum N, Siam NH, Nuren N, Pandru P. Diabetic retinopathy: an overview on mechanism, pathophysiology and pharmacotherapy. Diabetology 2022; 3: 159–175.

https://doi.org/10.3390/diabetology3010011.

5. Lu Y, Wang W, Liu J, Xie M, Liu Q, Li S. Vascular complications of diabetes: A narrative review. Medicine 2023 ; 102(40): e35285.

https://doi.org/10.1097/MD.0000000000035285.

6. Duh EJ, Sun JK, Stitt AW. Diabetic retinopathy: current understanding, mechanism and treatment strategies. JCI Insight 2017; 2(14): e93751.https://doi.org/10.1172/jci.insight.93751.

7. Bilal M, Shahid M, Mahnoor S, Saeed H, Kumari U. Diabetes mellitus: is Pakistan the epicentre of the next pandemic? Chronic Dis Transl Med 2023; 28: 75–77.

https://doi.org/10.1002/cdt3.96.

8. Mumtaz SN, Fahim MF, Arslan M, Shaikh SA, Kazi U, Memon MS. Prevalence of diabetic retinopathy in Pakistan: a systematic review. Pak J Med Sci 2018; 34(2): 493–500.

https://doi.org/10.12669/pjms.342.13819.

9. Hassan B, Ahmed R, Li B, Noor A, Hassan ZU. A comprehensive study capturing vision loss burden in Pakistan (1990–2025): findings from the Global Burden of Disease (GBD) 2017 study. PLoS One 2019; 14(5): e0216492.

https://doi.org/10.1371/journal.pone.0216492.

10. Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan BB, et al. Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract 2022; 183: 109-119.

https://doi.org/10.1016/j.diabres.2021.109119.

11. Aamir AH, Ul-Haq Z, Mahar SA, Qureshi FM, Ahmad I, Jawa A, et al. Diabetes Prevalence Survey of Pakistan (DPS PAK): prevalence of type 2 diabetes mellitus and prediabetes using HbA1c: a population-based survey from Pakistan. BMJ Open 2019; 9(2): e025300.

https://doi.org/10.1136/bmjopen-2018-025300.

12. Basit A, Askari S, Zafar J, Riaz M, Fawwad A. NDSP 06: prevalence and risk factors for obesity in urban and rural areas of Pakistan: a study from second National Diabetes Survey of Pakistan (NDSP), 2016–2017. Obes Res Clin Pract 2021; 15(1): 19–25.

https://doi.org/10.1016/j.orcp.2020.11.007

13. Corcóstegui B, Durán S, González-Albarrán MO, Hernández C, Ruiz-Moreno JM, Salvador J, et al. Update on diagnosis and treatment of diabetic retinopathy: a consensus guideline of the working group of ocular health (Spanish Society of Diabetes and Spanish Vitreous and Retina Society). J Ophthalmol 2017; 2017: 8234186. https://doi.org/10.1155/2017/8234186

14. Yau JWY, Rogers SL, Kawasaki R, Lamoureux EL, Kowalski JW, Bek T, et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care 2012; 35(3): 556–564.

https://doi.org/10.2337/dc11-1909

15. Teo ZL, Tham YC, Yu M, Chee ML, Rim TH, Cheung N, et al. Global prevalence of diabetic retinopathy and projection of burden through 2045: systematic review and meta-analysis. Ophthalmology 2021; 128(10): 1580–1591.

https://doi.org/10.1016/j.ophtha.2021.04.027.

16. 16. Azeem S, Khan U, Liaquat A. The increasing rate of diabetes in Pakistan: a silent killer. Ann Med Surg 2022; 79: 103901.

https://doi.org/10.1016/j.amsu.2022.103901.

17. Memon S, Ahsan S, Riaz Q, Basit A, Sheikh SA, Fawad A, et al. Frequency, severity and risk indicators of retinopathy in patients with diabetes screened by fundus photographs: a study from primary health care. Pak J Med Sci 2014; 30(2): 366–372 https://doi.org/10.12669/pjms.302.4086

18. Jokhio AH, Talpur KIQ, Shujaat S, Talpur S, Rafeen B, Memon S. Prevalence of diabetic retinopathy in rural Pakistan: a population based cross sectional study. Indian J Ophthalmol 2022; 70(6): 4364–4369. https://doi.org/10.4103/ijo.IJO_126_22.

19. Katulanda P, Ranasinghe P, Jayawardena R. Prevalence of retinopathy among adults with self reported diabetes mellitus: the Sri Lanka diabetes and Cardiovascular Study. BMC Ophthalmol 2014; 14: 100.

https://doi.org/10.1186/1471-2415-14-100.

20. Adnan M, Aasim M. Prevalence of type 2 diabetes mellitus in adult population of Pakistan: a meta-analysis of prospective cross sectional surveys. Ann Glob Health 2020; 86(1): 7.

https://doi.org/10.5334/aogh.2679.

21. Vashist P, Senjam SS, Gupta NV, et al. Prevalence of diabetic retinopathy in India: results from the national survey 2015–19. Indian J Ophthalmol 2021; 69(11): 3087–3089.

https://doi.org/10.4103/ijo.IJO_1310_21.

22. Sharif S, Manzoor F, Khan F, Naz S. Prevalence of diabetic retinopathy in diabetic subjects visiting diabetic centers of Lahore, Pakistan. Pakistan J Health Sci 2024; 5(2): 1299.

https://doi.org/10.54393/pjhs.v5i02.1299.

23. Scanlon PH, Aldington SJ, Leal J, Abdalla M, Foy C, Martin K, et al. What have we learned from the English National Screening Programme for diabetic retinopathy? Diabetes Ther 2018; 9(2): 837-847.https://doi.org/10.1007/s00592-017-0974-1.

24. Alabdulwahhab KM. Diabetic Retinopathy Screening Using Non-Mydriatic Fundus Camera in Primary Health Care Settings - A Multicenter Study from Saudi Arabia. Int J Gen Med 2023; 16: 2255-2262.https://doi.org/10.2147/IJGM.S410197